![ECOG-ACRIN logo[19516]275×75](https://blog-ecog-acrin.org/wp-content/uploads/2021/03/ECOG-ACRIN-logo19516275x75.png)
June 11, 2025
Dr. Grivas is honored as an international key opinion thought leader who has made outstanding contributions to genitourinary cancer research, clinical practice, leadership, teaching and mentorship, and community outreach
April 24, 2025
The changes broaden eligibility for this cancer care delivery study, which aims to improve medication adherence for patients with breast cancer
April 24, 2025
These two trials are open and enrolling adolescent and young adult survivors and patients with cancer
April 24, 2025
April 24, 2025
Summaries and links to timely information about research results presented at medical meetings, recognition of research leaders, and more
March 21, 2025
The changes significantly broaden eligibility and clarify key details in this phase 3 trial exploring whether adding radiation therapy to standard immunotherapy will improve survival in patients with stable disease after initial treatment
February 19, 2025
This is the first randomized phase 3 study to evaluate autologous stem cell transplantation in patients with this rare and aggressive form of non-Hodgkin lymphoma
February 19, 2025
Seven ground-breaking findings from cancer clinical trials in 2024 by ECOG-ACRIN and PrECOG
February 19, 2025
Summaries and links to timely information about research results presented at medical meetings, recognition of research leaders, and more
June 25, 2025
This trial is evaluating a new drug combination for patients with cancer that has relapsed after remission or no longer responds to standard treatment
December 23, 2024
Julie Brahmer, Naomi Haas, and Jedd Wolchok offer insights into a complicated issue that pertains to biomarker testing for treatment selection
December 23, 2024
This major new initiative is a unique opportunity for researchers and patients to help build an important real-world data registry of patients with EGFR-mutated non-small cell lung cancer